Searchable abstracts of presentations at key conferences in endocrinology

ea0085p88 | Thyroid | BSPED2022

Hypothyroidism - unknown through the known

Seenivasan Abinaya , Tamilselvan Kanimozhi , Jones Stephanie , Matei Cristina

Hypothyroidism is a well-known cause of delayed puberty in children. But in rare instances, hypothyroidism can also be related to isolated menarche. The mechanism remains debatable whilst the overall incidence of the condition remains unknown.Case Report: 6-year girl presented to children’s emergency with 2 days history of vaginal bleeding. Mum reported her being intolerant to cold, constipated and faltering growth compared to her twin sister. Her s...

ea0086p14 | Adrenal and Cardiovascular | SFEBES2022

Factors which contribute to LDL-C target attainment in familial hypercholesterolaemia

Vineall Owen , Jones Ben , Cegla Jaimini , David Alessia

Background: In the UK, NICE guidelines for familial hypercholesterolaemia (FH) recommend a greater than 50% reduction in low-density lipoprotein-cholesterol (LDL-C) as the therapeutic target. However, despite the availability of a range of lipid lowering medication, this target is often difficult to achieve and, more importantly, maintain life-long. Understanding factors that affect LDL-C target achievement is key to reducing cardiovascular disease (CVD) risk. Currently, there...

ea0086p163 | Adrenal and Cardiovascular | SFEBES2022

Validating the cholesterol-year-score as a predictor of major cardiovascular events in familial hypercholesterolaemia

Vineall Owen , Jones Ben , David Alessia , Cegla Jaimini

Background: Cardiovascular disease (CVD) risk in familial hypercholesterolaemia (FH) is driven by cumulative exposure to high low-density lipoprotein cholesterol (LDL-C) levels. Previously, LDL-C burden has been loosely approximated using the cholesterol year score (CYS) based on two LDL-C readings only. We aimed to determine whether a more sophisticated LDL-C burden score based on serial LDL-C measurements, could more accurately predict major atherosclerotic cardiovascular ev...

ea0086p59 | Metabolism, Obesity and Diabetes | SFEBES2022

The role of glucocorticoid activation by 11bHSD1 for muscle wasting in a mouse model of renal impairment

Sagmeister Michael , Crastin Ana , Jones Simon , Harper Lorraine , Hardy Rowan

Background: Chronic kidney disease aggravates loss of skeletal muscles mass and function, which is an independent risk factor for hospitalisation, morbidity and mortality. Glucocorticoid signalling has been implicated as a critical factor in the pathogenesis of muscle atrophy in kidney disease. This study tests whether genetic deletion of the glucocorticoid-activating enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11bHSD1) protects against muscle atrophy in the adenine-die...

ea0086p216 | Metabolism, Obesity and Diabetes | SFEBES2022

Simvastatin regulates Il10 gene expression in male and female murine macrophages

Sheridan Alanah , Wheeler-Jones Caroline , Gage Matthew C.

Statins are among the most widely prescribed medications worldwide, decreasing the risk of cardiovascular diseases by reducing cholesterol levels. However, statins also increase the risk of incident type 2 diabetes (T2D), disproportionately affecting women compared to men. Inflammation has emerged as a central factor underpinning T2D pathology, with macrophages playing a significant role. Statins have been found to influence macrophage inflammatory responses, and this has been...

ea0086p340 | Metabolism, Obesity and Diabetes | SFEBES2022

"Severe Lipaemia" with triglyceride levels above 100 mmol/L: successfully treated with insulin therapy alone

Tahir Chohan Muhammad , Aboushareb Fathy , Shah Ahmad , Jones Susan

Introduction: Commonest causes of pancreatitis are alcohol and gallstones but less common causes like hypertriglyceridemia should also be considered as management may differ.Case history: 47 years old gentleman with history of pancreatitis and hyperlipidaemia type1 taking atorvastatin and bezafibrate, admitted with severe abdominal pain and vomiting. He was non-smoker and non-drinker. No history of cholelithiasis or medications causing pancreatitis. He w...

ea0090p499 | Thyroid | ECE2023

Radioiodine therapy outcomes in benign thyroid disease at the University Hospital of Wales, UK

Nagarajah Kalyani , Jones Elizabeth , Witczak Justyna , Taylor Peter , Lansdown Andrew

Background: Radioiodine therapy (I-131) is commonly prescribed for benign thyroid disease in keeping with recommended guidelines.Aims: To determine the effectiveness of I-131 in treating benign thyroid disease and the rates of hypothyroidism following treatment and by diagnosis.Methods: We identified 100 patients who received radioiodine therapy between November 2013 and June 2015 from a database held in the Medical Physics Departm...

ea0065p41 | Adrenal and Cardiovascular | SFEBES2019

Use of sub-cutaneous pump for continuous hydrocortisone administration in patient with bilateral adrenalectomy and small bowel injury complicated by enterocutaneous fistula

Britt Penelope , Murphy June , Newland-Jones Phil , Bujanova Jana

We present a case of 39y old male who underwent adrenalectomy and aortic lymph node dissection for neuroendocrine tumour in context of underlying VHL disease and previous adrenalectomy. Iatrogenic injury to his duodenum resulted in prolonged, multiple intraabdominal infections and development of enterocutaneous fistula. He had to remain NBM, relied on high dose iv hydrocortisone administration and TPN feed for several months. Conversion back to oral steroids was considered unr...

ea0065p200 | Metabolism and Obesity | SFEBES2019

A role for kisspeptin in long-term islet function in females

Smith Lorna , Hill Thomas , Simpson Sian , Jones Peter , Bowe James

Although characterised predominantly for its role in the brain, the neuropeptide kisspeptin has previously been shown to potentiate glucose-stimulated insulin through its receptor, GPR54; expressed abundantly in β-cells. We have previously reported a physiological role for kisspeptin signalling in the islet adaptation to pregnancy, using a β-cell specific GPR54 knockout mouse line (βGPR54ko). The aim of the present study was to examine the effects of impaired &#...

ea0065p206 | Metabolism and Obesity | SFEBES2019

Role of palmitoylation on GLP-1 receptor responses in pancreatic beta cells

Lyu Zekun , Piedade Carolina , Bitsi Stavroula , Jones Ben , Tomas Alejandra

We have previously described how signaling responses for the glucagon-like peptide-1 receptor (GLP-1R), a class B GPCR that plays key roles in metabolic regulation and is a prime type 2 diabetes (T2D) target, are modulated by intracellular membrane trafficking. We have also recently shown that binding to the therapeutic GLP-1R agonist exendin-4 (Exenatide) triggers increased clustering and segregation of biologically active GLP-1Rs into cholesterol-rich plasma membrane nanodom...